Partners Group Holding Valuation
Is PGHN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of PGHN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: PGHN (CHF1170.5) wird über unserer Schätzung des Fair Value (CHF1079.59) gehandelt.
Deutlich unter dem Marktwert: PGHN über unserer Schätzung des beizulegenden Zeitwerts gehandelt wird.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PGHN?
Other financial metrics that can be useful for relative valuation.
| What is PGHN's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CHF33.10b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 17.7x |
| Enterprise Value/EBITDA | 28.5x |
| PEG Ratio | 2.3x |
Price to Earnings Ratio vs Peers
How does PGHN's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 18.3x | ||
BAER Julius Bär Gruppe | 24x | 20.6% | CHF10.9b |
VZN VZ Holding | 23x | n/a | CHF4.3b |
EFGN EFG International | 12x | 3.8% | CHF3.4b |
VONN Vontobel Holding | 14.1x | 10.8% | CHF3.0b |
PGHN Partners Group Holding | 33x | 14.5% | CHF33.1b |
Price-To-Earnings gegen Gleichaltrige: PGHN ist auf der Grundlage des Price-To-Earnings Verhältnisses (27.8x) im Vergleich zum Durchschnitt der Vergleichsgruppe (14.8x) teuer.
Price to Earnings Ratio vs Industry
How does PGHN's PE Ratio compare vs other companies in the European Capital Markets Industry?
Price-To-Earnings gegen Industrie: PGHN ist teuer, wenn man sein Price-To-Earnings Verhältnis (27.8x) mit dem European Capital Markets Branchendurchschnitt (15.8x) vergleicht.
Price to Earnings Ratio vs Fair Ratio
What is PGHN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 33x |
| Fair PE Ratio | 20.6x |
PM vs. Fair Ratio: PGHN ist teuer auf der Grundlage des Verhältnisses Price-To-Earnings (27.8x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Earnings (12.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CHF1,274.00 | CHF1,256.23 -1.4% | 9.4% | CHF1,450.00 | CHF1,040.00 | n/a | 13 |
| Mar ’25 | CHF1,264.50 | CHF1,181.64 -6.6% | 10.0% | CHF1,360.00 | CHF920.00 | n/a | 14 |
| Feb ’25 | CHF1,173.00 | CHF1,155.21 -1.5% | 9.4% | CHF1,350.00 | CHF920.00 | n/a | 14 |
| Jan ’25 | CHF1,213.00 | CHF1,097.57 -9.5% | 11.5% | CHF1,289.00 | CHF860.00 | n/a | 14 |
| Dec ’24 | CHF1,155.50 | CHF1,081.57 -6.4% | 11.3% | CHF1,289.00 | CHF860.00 | n/a | 14 |
| Nov ’24 | CHF967.20 | CHF1,054.64 +9.0% | 11.6% | CHF1,289.00 | CHF860.00 | n/a | 14 |
| Oct ’24 | CHF1,034.50 | CHF1,054.64 +1.9% | 11.6% | CHF1,289.00 | CHF860.00 | n/a | 14 |
| Sep ’24 | CHF953.80 | CHF1,019.84 +6.9% | 15.0% | CHF1,491.00 | CHF860.00 | n/a | 14 |
| Aug ’24 | CHF978.00 | CHF1,018.51 +4.1% | 14.5% | CHF1,491.00 | CHF860.00 | n/a | 15 |
| Jul ’24 | CHF841.60 | CHF988.65 +17.5% | 8.9% | CHF1,120.03 | CHF848.00 | n/a | 14 |
| Jun ’24 | CHF825.20 | CHF960.08 +16.3% | 16.2% | CHF1,120.03 | CHF480.11 | n/a | 15 |
| May ’24 | CHF863.20 | CHF946.80 +9.7% | 16.4% | CHF1,100.00 | CHF480.11 | n/a | 14 |
| Apr ’24 | CHF856.80 | CHF985.41 +15.0% | 20.5% | CHF1,491.00 | CHF480.11 | CHF1,288.00 | 15 |
| Mar ’24 | CHF879.80 | CHF1,015.69 +15.4% | 20.8% | CHF1,491.00 | CHF480.11 | CHF1,264.50 | 15 |
| Feb ’24 | CHF860.40 | CHF1,015.69 +18.0% | 20.8% | CHF1,491.00 | CHF480.11 | CHF1,173.00 | 15 |
| Jan ’24 | CHF816.80 | CHF1,137.11 +39.2% | 21.1% | CHF1,540.00 | CHF480.11 | CHF1,213.00 | 15 |
| Dec ’23 | CHF947.20 | CHF1,153.51 +21.8% | 20.8% | CHF1,540.00 | CHF480.11 | CHF1,155.50 | 14 |
| Nov ’23 | CHF897.40 | CHF1,162.65 +29.6% | 20.6% | CHF1,540.00 | CHF480.11 | CHF967.20 | 14 |
| Oct ’23 | CHF804.60 | CHF1,255.67 +56.1% | 17.3% | CHF1,590.00 | CHF765.40 | CHF1,034.50 | 14 |
| Sep ’23 | CHF902.60 | CHF1,279.29 +41.7% | 17.1% | CHF1,600.00 | CHF765.40 | CHF953.80 | 15 |
| Aug ’23 | CHF1,033.00 | CHF1,328.03 +28.6% | 22.0% | CHF1,840.00 | CHF765.40 | CHF978.00 | 14 |
| Jul ’23 | CHF860.40 | CHF1,448.74 +68.4% | 18.7% | CHF1,840.00 | CHF765.40 | CHF841.60 | 14 |
| Jun ’23 | CHF992.20 | CHF1,560.92 +57.3% | 13.9% | CHF1,935.86 | CHF1,040.00 | CHF825.20 | 14 |
| May ’23 | CHF1,047.50 | CHF1,630.20 +55.6% | 9.8% | CHF1,935.86 | CHF1,400.00 | CHF863.20 | 14 |
| Apr ’23 | CHF1,145.50 | CHF1,634.07 +42.7% | 9.9% | CHF1,935.86 | CHF1,400.00 | CHF856.80 | 13 |
Analysten-Prognose: Das Kursziel ist niedriger als der aktuelle Aktienkurs.